Company Description
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products.
The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.
It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.
In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.
It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online.
The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau.
USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Country | United States |
IPO Date | Apr 4, 1994 |
Industry | Packaged Foods |
Sector | Consumer Defensive |
Employees | 1,800 |
CEO | Jim Brown |
Contact Details
Address: 3838 West Parkway Boulevard Salt Lake City, Utah United States | |
Website | https://www.usana.com |
Stock Details
Ticker Symbol | USNA |
Exchange | NYSE |
Fiscal Year | February - January |
Reporting Currency | USD |
CIK Code | 0000896264 |
CUSIP Number | 90328M107 |
ISIN Number | US90328M1071 |
Employer ID | 87-0500306 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Jim Brown | Chief Executive Officer & President |
G. Douglas Hekking | Chief Financial Officer |
P. Joshua Foukas J.D. | Chief Legal Officer, General Counsel & Corporate Secretary |
Peter Benedict | Chief Information Officer |
Walter Noot | Chief Operating Officer |
Daniel A. Macuga Jr. | Chief Communications & Marketing Officer |
Dr. John Cuomo | Executive Director of Product Development & Technology |
Dr. Myron W. Wentz Ph.D. | Founder & Chairman Emeritus |
Dr. Robert A. Sinnott M.N.S., Ph.D. | Chief Scientific Officer |
Kevin G. Guest | Executive Chairman |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 18, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 10-Q | Quarterly Report |
Nov 05, 2024 | 4 | Filing |
Nov 05, 2024 | 4 | Filing |
Oct 22, 2024 | 8-K | Current Report |